Statistics
Publications
5
Citations
292
H-Index
5
Active since
2020
Changlun Wang is an author at Peking University specializing in radiopharmaceutical design, cancer pharmacology, and targeted prodrug activation.
Publications per year
2020–2024
5
5
Covalent targeted radioligands potentiate radionuclide therapy
Xi‐Yang Cui, Zhu Li, Ziren Kong et al. · Nature · 2024 · 165 citations
Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy
Changlun Wang, Mengxin Xu, Zihang Zhang et al. · Science Bulletin · 2024 · 16 citations
Medicine, Oncology, Pharmaceutics +14
China’s radiopharmaceuticals on expressway: 2014–2021
Xi‐Yang Cui, Yu Liu, Changlun Wang et al. · Radiochimica Acta · 2022 · 11 citations
Medicine, Pharmacology, Radiology +14
1–5 of 5